Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Early Stage Severe Sepsis

NCT00568737 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00568737
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00568737 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Early Stage Severe Sepsis
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2002
Completion date
February 28, 2005
Enrollment
2,640 (actual)
Sites
70

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis